Physician profile
Dolly Ubhrani
NPI 1306036850
$1,691.16
in general payments reported to CMS, 2019-2025
20 companies · $136 in 2025
The $136 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295 · 2020: $190 · 2021: $240 · 2022: $162 · 2023: $270 · 2024: $398 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $804.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $339.17 | 2019-2024 | |
| Tris Pharma INC | $249.34 | 2019-2025 | Dyanavel Xr, Onyda Xr |
| Cranial Technologies, INC | $177.45 | 2019-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $163.89 | 2020-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Sanofi Pasteur INC. | $118.86 | 2019-2024 | |
| Glaxosmithkline, LLC. | $91.64 | 2023-2025 | Bexsero, Penmenvy, Pediarix |
| Ironshore Pharmaceuticals INC. | $88.99 | 2019-2023 | Jornay Pm |
| Corium, LLC | $77.38 | 2021-2024 | Azstarys |
| Supernus Pharmaceuticals, INC. | $66.59 | 2024-2025 | Qelbree |
| Hologic Sales and Service, LLC | $41.30 | 2022-2024 | Aptima |
| Seqirus USA INC | $40.18 | 2021-2024 | Flucelvax |
| Abbvie INC. | $39.34 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $38.47 | 2023-2024 | |
| Genentech USA, INC. | $36.45 | 2020-2021 | |
| Shire North American Group INC | $34.26 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $24.71 | 2024 | Flumist Quadrivalent |
| Phadia US INC. | $17.93 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.21 | 2020 | |
| Alk-Abello, INC | $15.25 | 2025 | Neffy |
| Adlon Therapeutics L.P. | $12.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dolly Ubhrani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.